2025 Annual Meeting | H79 - BrainPAC: The Superpower Behind Every Advocate and How to Activate It (Practice and Policy Hub)

Date Sunday 04/06/25

Time 03:30 PM - 04:15 PM PDT Add To Calendar

Location San Diego Convention Center | 20D Lobby

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) Jeremy K. Cutsforth-Gregory, MD, FAAN, Aileen Antonio, MD, FAAN

Topic(s) General Neurology

Learning Objectives This session is your roadmap to becoming a BrainPAC champion! You'll learn the best strategies in peer-to-peer fundraising and discover how the AAN engages policymakers to advance brain health and neurology. Equip yourself with the tools and knowledge to navigate the political process, make a lasting impact, and drive meaningful change. Get ready to take action, achieve your goals, and play a key role in shaping the future of neurologic care!

CME Available 0.75 CME credit

Core Competencies Interpersonal and Communication Skills, Professionalism, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator, Coordinator

Teaching Styles Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:15 PM PDT	Speaker	BrainPAC: The Superpower Behind Every Advocate and How to Activate It Jeremy K. Cutsforth-Gregory, MD, FAAN, Aileen Antonio, MD, FAAN, Nina Y. Riggins, MD, FAAN

Faculty Disclosures
Jeremy K. Cutsforth-Gregory, MD, FAAN	Dr. Cutsforth-Gregory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Aileen Antonio, MD, FAAN	Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. The institution of Dr. Antonio has received research support from Saint Mary's Foundation.
Nina Y. Riggins, MD, FAAN	Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.

��ɫ��

��ɫ��